Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    

| More

BUY on GIC Reinsurance - Arduous Road Ahead - HDFC Securities

Posted On: 2020-07-02 04:42:18

Mr. Madhukar Ladha, Institutional Research Analyst, HDFC Securities.

GIC Reinsurance (Q4FY20 Results Review): Arduous Road Ahead. BUY
(TP Rs 185, CMP Rs 155, MCap Rs 272bn)

Higher losses in agriculture and aviation led to increased 4QFY20 claims ratio of 89.1%, +1,917/-1,788bps YoY/QoQ. This resulted in underwriting losses of Rs 7.2bn. Investment income was hit by higher provisions of Rs 3.8bn bringing yield down to 7.7%. 4QFY20 APAT was Rs 12.2bn (+37.5% YoY).

NEP: Led by healthy growth in property/health i.e., 71.7/17.5% YoY, 4QFY20 NEP grew 43.6% YoY to Rs 76.6bn. For FY20 the company delivered an NEP of Rs 443.5bn (+16.0% YoY).

CORs: 4QFY20 CORs (cal.) increased 1,676bps YoY to 107.5% as ICR increased 1,917bps YoY to 89.1%. FY20 CORs (cal.) increased 929bps YoY to 114.5% as ICR increased 848bps YoY to 97.3%. This was mainly due to high losses in crop and fire.

Crop's share in 4Q/FY20 NWP was 7.5/29.9% but its share in underwriting losses was higher at 377.1/56.5% as 1) losses due to unseasonal rainfall mainly in MH and MP leading to post harvest losses, and 2) loss development on crop portfolio for FY19. Management stated that crop losses should reduce FY21 onwards as the company had reduced its capacity to ~Rs 80bn (-40% YoY) and implemented stricter loss corridors.

Investment book declined materially to Rs 702bn (-10.9/-12.4% YoY/QoQ) due to MTM hit on account of equity losses. 4QFY20 realized inv. yields (net of provisions) was at 7.7% (annualized). Investment yield (incl. FV change) declined to -20.3% (vs. 8.2% in FY19). On FV basis equity accounts for 35% of exposure. Duration of the fixed income book is ~7-10 yrs.

GICRE provided Rs 3.8bn for doubtful debts and investment assets. Management highlighted that it has provided for 100% for secured as well as unsecured portion of ILFS (Rs 7.9bn) and DHFL (Rs 2.1bn). Exposure to ADAG was secured/unsecured at Rs 2.95/1.64bn. Co has provided for 15% secured and 100% unsecured portion.

Management stated that it will book investment gains to shore up solvency, which is now at just 153! Solvency (incl. investment gains) stands strong at ~300%. Adj. for FV change (net of tax), GICRE's annualized ROE for FY20 works out to -28.8%.

STANCE: GICRE is India's largest reinsurer but continues to make high underwriting losses (FY20 COR: 113.8%). A calibrated approach to underwriting is expected to change this over FY21-23E. While we are not fully convinced about the pathway to underwriting profitability, inexpensive valuations- FY22E P/ABV of 0.6x result in our BUY recommendation with a TP of Rs 185. We estimate an FY22E adj. RoE at 7.4%, and value GICRE at 0.7x FY22E ABV less 10% discount. We continue to rate GICRE a BUY with a TP of Rs 185 (Mar-22E P/ABV of 0.6x).

Shares of General Insurance Corporation of India was last trading in BSE at Rs.151.5 as compared to the previous close of Rs. 149.15. The total number of shares traded during the day was 31986 in over 1210 trades.

The stock hit an intraday high of Rs. 154.3 and intraday low of 151.1. The net turnover during the day was Rs. 4871504.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Cadila Healthcare - Q1FY21 First Cut - ICICI Securities

Dwarikesh Sugar - Q1FY21 First Cut - ICICI Securities

Jyothy Lab - Q1FY21 First Cut - ICICI Securities

Avenue Supermarts - Company Update - August 2020 - ICICI Securities

Hawkins Cookers - 1QFY21 Results - Angel Broking

Maintain REDUCE on Godrej Consumers - Strong comeback in H1 - HDFC Securities

ADD on Gujarat Gas - A complete washout quarter - HDFC Securities

SELL on Vinati Organics - At an inflexion point - HDFC Securities

Expectations from the upcoming RBI Policy - HDFC Securities

AXIS Bank - 10,000 Cr QIP - Angel Broking

PI Industries - Mr. Jyoti Roy, DVP - Equity Strategist, Angel Broking Ltd.

Maintain BUY on Teamlease Services - Recovery on the cards ICICI Securities

Reiterate ADD on Tata Motors - Volatile environment - ICICI Securities

Tata Consumer Products Ltd - 1QFY21 results - Rajit Rajoriya, Equity Research Associate, Angel Broking Ltd

Maintain REDUCE On Karur Vysya Bank - Pain inevitable - HDFC Securities

Sovereign Gold Bonds - Thematic Report - ICICI Securities

Varun Beverages - Q2CY20 Result Update - ICICI Securities

Saregama India - Company Update - August 2020 - ICICI Securities

Exide Industries - Q1FY21 Result Update - ICICI Securities

Indian Oil Corporation - Q1FY21 Result Update - ICICI Securities

Maintain ADD on Indian Oil Corporation - High inventory losses drag earnings - HDFC Securities

Maintain BUY on Cholamandalam Investment & Finance - A mostly good show - HDFC Securities

Maintain ADD on BSE - Fighting its way back - HDFC Securities

Maintain ADD on Motilal Oswal Financial Services - In-line performance - HDFC Securities

Maintain BUY on Sobha - A smooth ride with few bumps - HDFC Securities

Banking Sector Credit Trends Report - Growth slows, as expected - HDFC Securities

Maintain ADD on Sun Pharma - Cost savings drive the quarterly beat - HDFC Securities

Auto Sector Performance - July'20 - Angel Broking

Sector Thematic on Indian Gas Sector - Looking beyond the pandemic - HDFC Securities

ADD on Max Financial - Lower margins despite higher protection - HDFC Securities

Maintain BUY on Mastek - Changing orbit - HDFC Securities

Mantain REDUCE On Dabur - In-line 2Q, slight beat in domestic volume - HDFC Securities

CreditAccess Grameen - Q1FY21 - YES Securities

ADD on Torrent Pharma - Resilient performance - HDFC Securities

BSE Limited - Pricing pressure remains a challenge - ICICI Securities

Kansai Nerolac Paints - Better-than-expected trajectory in decorative paints -

VA Tech Wabag - High receivables, low margins to impact earnings - ICICI Securities

CreditAccess Grameen - Customer activation trend shows resilience - ICICI Securities

Tata Chemicals - Q1FY21 Result Update - ICICI Securities

VST Industries - Q1FY21 Result Update - ICICI Securities

ADD on Navin Fluorine International - Commendable performance - HDFC Securities

Whirlpool of India - Valuations belie outlook; risk-reward unfavourable - ICICI Securities

Kansai Nerolac - Q1FY21 First Cut - ICICI Securities

Exide Industries - Q1FY21 First Cut - ICICI Securities

Monthly Auto Volumes - July, 2020 - ICICI Securities

Cholamandalam Investments and Finance Company Ltd - Q1FY21 Result Update - YES Securities

Mahindra logistics - Q1FY21 Result Update - YES Securities

Bluedart Express - Q1FY21 Result Update - YES Securities

Tata Motors - Cost improvements reassuring - ICICI Securities

Godrej Agrovet - Deflation in input prices leads to higher margin - ICICI Securities

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019